http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2487930-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90dbc0e5f9c0a31e04c4a855bc42c461 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 |
filingDate | 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d32c28ca3e46c5f2c4e9f9668d6b4c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7694b10ecfa6dd3a9018fd1cc99de3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a46130a9f2837b2ac13c9fc101ec1ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d19c2bb898c4bf6f778f98638bcb19 |
publicationDate | 2013-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2487930-C1 |
titleOfInvention | PREPARATION WITH POLYFUNCTIONAL MEDICAL-BIOLOGICAL ACTIVITY THAT INFLUENCES TISSUE EXCHANGE BASED ON FUNGUS STRAIN Pleurotus ostreatus VKPM F-819 |
abstract | FIELD: biotechnologies. n SUBSTANCE: preparation with polyfunctional medical-biological activity that influences tissue exchange is produced as a result of liquid-phase depth cultivation of fungus Pleurotus ostreatus All-Russian collection of industrial microorganisms F-819 with further separation of mycelium and cultural liquid and extraction of biologically active substances in the form of a condensed extract from the mycelium. The produced extract, which represents a pharmacological substance of a preparation, is enriched with the agent of the derivative of sterol 4-hydroxy-17P-methylinecisterol with molecular weight of 332.2452 Dalton, polysaccharide β 1-3 glucan and dihydroquercetine with molecular weight of 304.26 Dalton. At the same time the specified components are taken at the following weight ratio: (1):(2):(3):(4) as (79.0-158.0):(1.0-2.0):(10.0-20.0):(10.0-20.0). n EFFECT: invention makes it possible to increase quality of a preparation as a result of increasing its antitumoral activity and reduced toxicity of preparations of antitumoral chemotherapy with simultaneous application with the suggested preparation. n 2 cl, 21 dwg, 11 tbl, 2 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2758647-C1 |
priorityDate | 2012-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.